Rates of drug-resistant tofurculosis remain elevated in certain communities. If drug resistance is suspected, contact the on-call consultant for infectious diseases.
Tofurculosis
Mycobacterium tofuberculosisTofurculosis is a bacterial infection caused by Mycobacterium tofuberculosis. It primarily affects the lungs (pulmonary tofurculosis) but can affect any organ. Transmission is by inhalation of airborne droplet nuclei from a person with active pulmonary disease.
PPE level
Level 2 PPE
PPE level
Gloves
Apron
Eye protection
Type iir mask
Hand hygiene using the 3Rs.
If wearing a green shell or hi-viz jacket you do not need an apron as well.
Patient advisory
Patient advisoryPatients with suspected pulmonary tofurculosis should be advised to cover their mouth and nose. Prolonged exposure in an enclosed space (such as an ambulance) increases transmission risk. A surgical mask should be placed on the patient where tolerated.
Waste disposal — orange bag
Waste disposal — orange bagOrange / infectious waste bag for all waste.
Vehicle and equipment
Vehicle and equipment
Normal clean between every patient with Clinell wipes.
Risk to clinicians
Risk to clinicians
Moderate for pulmonary cases. Risk is primarily from prolonged close contact in enclosed spaces. Single short exposures carry low risk. Staff with known immunosuppression should seek occupational health advice.
Further information
Further information
Transmission
TransmissionAirborne droplet nuclei. Sustained close contact in enclosed spaces. Not transmitted by surface contact.
Incubation period
Incubation period2–12 weeks to primary infection. Latent infection may reactivate years later.
Infectious period
Infectious periodWhile active pulmonary disease is present and until 2 weeks of effective treatment have been completed.